constructed the Chinese Prostate Cancer Consortium Risk Calculator (CPCC-RC) that is based on prostate-specific antigen (PSA), age, prostate volume, free to total PSA (fPSA-to-tPSA) rate, and digital rectal examination (DRE) to predict the initial prostate biopsy. The gene discussed is KLK3; the disease is prostate cancer.